Nanjing Leads Biolabs Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Equivalents	431.38	372.54	247.52
Trading Asset Securities	75.08	166.18	100.13
Cash & Short-Term Investments	506.46	538.72	347.65
Cash Growth	-	54.96%	-
Other Current Assets	8.08	57.59	19.47
Total Current Assets	586.21	596.31	367.12
Property, Plant & Equipment	52.83	47.57	61.09
Other Long-Term Assets	29.19	25.57	19.27
Total Assets	668.83	669.44	447.48
Accounts Payable	2.94	3.52	0.22
Accrued Expenses	47.15	34.26	23.33
Current Portion of Long-Term Debt	255.22	255.21	61
Current Portion of Leases	6.42	5.72	4.31
Current Income Taxes Payable	0.42	0.78	0.9
Current Unearned Revenue	139.13	84.22	-
Other Current Liabilities	10.39	14.63	1,305
Total Current Liabilities	461.67	398.34	1,395
Long-Term Leases	14.28	5.55	1.78
Total Liabilities	476.17	403.88	1,396
Common Stock	156.5	156.5	17.02
Retained Earnings	-270.93	-195.56	-982.76
Comprehensive Income & Other	307.09	304.62	16.93
Shareholders' Equity	192.67	265.56	-948.81
Total Liabilities & Equity	668.83	669.44	447.48
Total Debt	275.92	266.48	67.09
Net Cash (Debt)	230.54	272.24	280.57
Net Cash Growth	-	-2.97%	-
Net Cash Per Share	1.51	1.81	1.94
Filing Date Shares Outstanding	156.5	156.5	144.85
Total Common Shares Outstanding	156.5	156.5	144.85
Working Capital	124.54	197.97	-1,027
Book Value Per Share	1.23	1.70	-6.55
Tangible Book Value	192.07	265.56	-948.81
Tangible Book Value Per Share	1.23	1.70	-6.55
Machinery	75.77	75.61	74.21
Construction In Progress	-	-	0.36
Leasehold Improvements	25.85	25.85	24.63

Source: S&P Global Market Intelligence. Standard template. Financial Sources.